Market Cap: $557.55M
CI
Contineum Therapeutics, Inc.
CTNM
NASDAQUSD
Market Cap: $557.55M
Filed a patent for "lpar1 antagonists and uses thereof" on Thu, February 1, 2024
New US PatentFiled a patent for "crystalline compound of an lpar1 antagonist" on Fri, January 27, 2023
New US PatentFiled a patent for "lpar1 antagonists and uses thereof" on Thu, February 1, 2024
New US PatentFiled a patent for "muscarinic acetylcholine m1 receptor antagonists" on Thu, November 16, 2023
New US PatentFiled a patent for "crystalline compound of muscarinic acetylcholine m1 receptor antagonists" on Fri, October 6, 2023
New US Patent